The Latest Cardiac and Vascular News
Images acquired with AI guidance software deemed usable in 100 percent of cardiac patients TEL AVIV, Israel, May 26, 2022 /PRNewswire/ — At the 69th Annual Conference of the Israel Heart Society, UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, and Sheba Medical Center Israel revealed new research findings from […]
CAMBRIDGE, Mass., May 26, 2022 /PRNewswire/ — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today announced the appointment of Drew Young as Chief Commercial Officer and Head of Patient Experience. Mr. Young is joining Anthos at a very exciting time in the company’s young history, bringing over […]
Presentation will highlight development of recent recommendation for low-level disinfection of transducers used in percutaneous procedures HARTWELL, Ga., May 26, 2022 /PRNewswire/ — A presentation at the upcoming annual meeting of the Infusion Nurses Society (INS) will discuss the recent development of a policy statement favoring low-level disinfection (LLD) as a safe […]
Commercial pipeline to include 30 advanced leads at Medical Centers of Excellence Company’s development and operational infrastructure will be on track to support anticipated sales growth following commercial rollout on July 1, 2022 BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity […]
MINNEAPOLIS, May 24, 2022 /PRNewswire/ — VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that it has completed enrollment of a randomized clinical trial (RCT) titled “FLEX Vessel Prep Prior To […]
Pioneer of AI-driven, epigenetics-based clinical tests for cardiovascular disease moves for Chicago’s thriving biotech ecosystem and access to talent and resources CHICAGO, May 25, 2022 /PRNewswire/ — Cardio Diagnostics, Inc. (“Cardio Diagnostics”), a company pioneering AI-driven, epigenetics-based clinical tests for cardiovascular disease (CVD), today announced they have relocated their headquarters to Chicago, Illinois. Cardio Diagnostics will be […]
WASHINGTON, May 25, 2022 /PRNewswire/ — MedStar Heart & Vascular Institute is pleased to announce that Thomas E. MacGillivray, MD, has been named physician executive director of Cardiac Surgery at MedStar Health, and chairman of Cardiac Surgery at MedStar Washington Hospital Center, effective September 1, 2022. Dr. MacGillivray will join MedStar Heart & Vascular […]
The ŌNŌ is intended to simplify bailout procedures in the expanding world of structural heart disease interventions PHILADELPHIA, May 25, 2022 (GLOBE NEWSWIRE) — ŌNŌCOR LLC, a leader in endovascular safety technology, today announced it has received 510(k) U.S. Food and Drug Administration (FDA) clearance for its ŌNŌ retrieval system, […]
Sovateltide produced a statistically significant and clinically meaningful improvement in neurological outcomes in acute cerebral ischemic stroke patients 90 days post-treatment Sovateltide demonstrated a highly favorable ordinal shift in the modified Rankin Scale (mRS) score and a significantly (p=0.0045) greater number of patients with an improvement of ≥2 points on the mRS […]
The Company’s flagship technology to be featured during a two-day educational conference that draws the world’s top cardiac electrophysiology experts Westport, CT, May 25, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity […]
